臨床研究等提出・公開システム

Date of registration	June. 01, 2026
Last modified on	June. 01, 2026
Trial ID	jRCT1050260064

Scientific Title	Acute Coronary Syndrome and Therapies with Lowering LDL-C (ACTION-LDLC)
Public Title	ACTION-LDLC (ACTION-LDLC)

Contact for Scientific Queries	Name	Kataoka Yu
	Affiliation	National Cerebral & Cardiovascular Center
	Address	Kishibe-shinmachi 6-1, Suita, Osaka, Japan
	Telephone	+81-6-6170-1069
	E-mail	yu.kataoka@ncvc.go.jp
Contact for Public Queries	Name	Kataoka Yu
	Affiliation	National Cerebral & Cardiovascular Center
	Address	Kishibe-shinmachi 6-1, Suita, Osaka, Japan
	Telephone	+81-6-6170-1069
	E-mail	yu.kataoka@ncvc.go.jp

Recruitment status	Recruiting

Anticipated date of first enrollment		June. 01, 2026
Actual date of first enrollment		May. 10, 2024
Target sample size		2000
Study Type		Observational
Study Design	allocation	single arm study
	masking	open(masking not used)
	control	uncontrolled control
	assignment	single assignment
	purpose	treatment purpose
Key inclusion & exclusion criteria	Inclusion Criteria	patients with who recieved PCI
	Exclusion Criteria	CAD due to non-atherosclerotic causes
	Age Minimum	20age old exceed
	Age Maximum	No limit
	Gender	Both
Health Condition(s) or Problem(s) Studied		CAD
Intervention(s)		none
Health Condition(s) Keyword		CAD
Primary Outcome(s)		MACE
Secondary Outcome(s)		componet of MACE

Primary Sponsor	none

Name of Certified Review Board	National Cerebral & Cardiovascular Center, research ethics committee
Address	Kishibe-shinmachi 6-1, Suita, Osaka, Japan, Osaka
Telephone	+81-6-6170-1070
E-Mail	rec-office-ac@ncvc.go.jp
Approval Status	Approval
Date of approval	April. 30, 2024

Plan to share IPD	No

Countries of Recruitment（Except Japan）	none